Events

This symposium explores the complex interactions between law and antimicrobial research and development. Advancing our understanding of this ecosystem will help design a better legal toolkit to promote antimicrobial innovation and limit the impact of resistance on global health. Held at the University of Cambridge, an international hub for legal and scientific expertise, we hope […]

We are excited to announce that CARB-X will be hosting our first ever CARB-X Developer Conference. The conference will be held on September 6th, 2019 in Boston, immediately following the conclusion of the ASM-ESCMID conference.  Additional details will follow.  Please save the date! This  will be an excellent networking event for CARB-X product developers, who will have […]

Additional Details Forthcoming.

In this webinar, Peter Warn will review the experimental design and conduct of advanced or complex animal models for antimicrobial research. This webinar is designed as a follow on from the webinar of William J. Weiss: Models for antimicrobial R&D: Development and use of in vivo models for infectious disease research (see here: http://bit.ly/2ZiPt6y). Topics […]

Join HHS Secretary, Alex Azar, experts from the U.S. Centers for Disease Control and Prevention, and hundreds of organizational and global leaders for an evening celebrating the culmination of the AMR Challenge at an unofficial side event of the 74th United Nations General Assembly in New York City.

Attendees include Richard Alm, CARB-X Alliance Director. IDWeek is the joint annual meeting of the Infectious Diseases Society of America (IDSA), Society for Healthcare Epidemiology of America (SHEA), the HIV Medical Association (HIVMA), and the Pediatric Infectious Diseases Society (PIDS). At IDWeek, you will see familiar colleagues and new faces. IDWeek is a forum for […]

In this webinar, Olga Genilloud will discuss the role of natural products in current antibiotic discovery. Topics discussed will include: Screening strategies to identify novel antibiotics Current challenges and novel analytical tools New omic approaches supporting antibiotic discovery The presentation will be followed by a Q&A session.   Speaker: Olga Genilloud, Scientific Director, Fundación MEDINA, […]

Despite drug resistance growing, the development of new antibiotics has slowed. How can policymakers help accelerate the pace of new drug development, and how can all of us—doctors, hospitals, and patients, as well as the agricultural sector—be better stewards of existing drugs? Forum panelists will examine the scope of this looming crisis and look at how changes in policy and practice can help us stay one step ahead of these superbugs.

Speakers include Erin Duffy, CARB-X Chief of Research and Development. The emergence and spread of bacteria resistant to many drug classes seriously threaten all branches of modern medicine. There is currently no course providing advanced instruction on antibiotics and resistance. The specific goal of ICARe is to bring leaders in academics and industry together with […]

Kevin Outterson, Executive Director of CARB-X, will be speaking at the Harvard Chan School of Public Health. This presentation is sponsored by Harvard Antimicrobial Resistance (HAMR) a subgroup of the Harvard Infectious Diseases Consortium. For more information, visit harvardamr.com